Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice?
Creighton Authors
Abuzaid, Ahmed S.
Abuzaid, Ahmed S.
Admin. Units
School of Medicine; Department of Medicine
School of Medicine; Department of Medicine
Title
Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice?
Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice?
Authors
Mahmoud, A.; Saad, M.; Elgendy, A. Y.; Abuzaid, A.; Elgendy, I. Y.
Mahmoud, A.; Saad, M.; Elgendy, A. Y.; Abuzaid, A.; Elgendy, I. Y.
Journal
Cardiovascular Therapeutics
Cardiovascular Therapeutics
Volume
33
Issue
4
Pages
227-235
33
Issue
4
Pages
227-235
Date
2015, August
2015, August
Metadata
Show full item record
Link
Check for Full-Text (may not be available)
Check for Full-Text (may not be available)
Citation
Mahmoud, A.; Saad, M.; Elgendy, A. Y.; Abuzaid, A.; Elgendy, I. Y. (2015). Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice? Cardiovascular therapeutics, 2015 August, 33(4):227-235. doi: http://doi.org/10.1111/1755-5922.12124
Mahmoud, A.; Saad, M.; Elgendy, A. Y.; Abuzaid, A.; Elgendy, I. Y. (2015). Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice? Cardiovascular therapeutics, 2015 August, 33(4):227-235. doi: http://doi.org/10.1111/1755-5922.12124